PPARα agonist 4
PPARα agonist 4 (compound BH400) is a PPARα agonist (EC50= 1.2 μM) . PPARα agonist 4 also inhibits STING (IC50: 8.1 μM) . PPARα agonist 4 reduces the CoCl2-induced production of ROS and LPS-induced secretion of IL-6. The PPARα agonist 4 restores the decreased expression of PCG1α induced by LPS[1].
Product Specifications
UNSPSC
12352005
Target
PPAR; Reactive Oxygen Species (ROS) ; STING
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pparα-agonist-4.html
Smiles
O=C(O)C1=CC(NCC2=CC=C(C3=CC=C(F)C=C3)C=C2)=CC=C1O
Molecular Formula
C20H16FNO3
Molecular Weight
337.34
References & Citations
[1]Bo Hu, et al. Design and Assessment of First-Generation Heterobifunctional PPARα/STING Modulators. ACS Medicinal Chemistry Letters Article ASAP
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
P21 / WAF1 (WA-1), CF568 conjugate, 0.1mg/mL
CD31 / PECAM-1 (158-2B3), CF568 conjugate, 0.1mg/mL
Histone H1 (AE-4), CF488A conjugate, 0.1mg/mL
CD100 (Semaphorin-4D) (A8), CF488A conjugate, 0.1mg/mL
